Pedro C. Rodríguez

A Phase III Clinical Trial of the Epidermal Growth Factor Vaccine CIMAvax-EGF as Switch Maintenance Therapy in Advanced Non–Small Cell Lung Cancer Patients

Pedro C. Rodríguez, Xitllaly Popa, Odeth Martínez et al. · Clinical Cancer Research · 2016 · 166 citations

Medicine, Immunology, Oncology +17

A clinical exploratory study with itolizumab, an anti-CD6 monoclonal antibody, in patients with rheumatoid arthritis

Pedro C. Rodríguez, Roberto Torres-Moya, Gil Reyes et al. · Results in Immunology · 2012 · 45 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +17

Safety, immunogenicity and preliminary efficacy of multiple-site vaccination with an Epidermal Growth Factor (EGF) based cancer vaccine in advanced non small cell lung cancer (NSCLC) patients

Pedro C. Rodríguez, Elia Neninger, Beatriz García Verdecia et al. · Journal of Immune Based Therapies and Vaccines · 2011 · 31 citations · Full text

Veterinary Medicine, Immunology, Oncology +17

Priming and boosting determinants on the antibody response to an Epidermal Growth Factor-based cancer vaccine

Pedro C. Rodríguez, Ileana González, Adys Gonzalez et al. · Vaccine · 2008 · 20 citations

Medicine, Immunology, Oncology +14

Differential effects of two therapeutic cancer vaccines on short- and long-term survival populations among patients with advanced lung cancer

Lizet Sánchez, Leacky Muchene, Patricia Lorenzo-Luaces et al. · Seminars in Oncology · 2018 · 17 citations

Medicine, Immunology, Oncology +16